DEA Accuses California-Based Online Pharmacy of Unlawfully Dispensing Stimulants Used To Treat ADHD

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

DEA Accuses California-Based Online Pharmacy of Unlawfully Dispensing Stimulants Used To Treat ADHD

Staff Writers

December 28, 2022 at 16:13:22 ET

On Dec. 15, the DEA served an order to show cause (OTSC) on an online retail pharmacy serving telehealth companies that allegedly filled thousands of unlawful prescriptions for stimulants used to treat attention deficit/hyperactivity disorder (ADHD). Hayward, California-based Truepill marketed ADHD treatments, including Adderall (amphetamine/dextroamphetamine) and generic forms of ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

DEA Accuses California-Based Online Pharmacy of Unlawfully Dispensing Stimulants Used To Treat ADHD

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT